ESR1 and breast cancer: Thus, today, BC is not considered as one disease, and when establishing a diagnosis, in addition to determining the anatomical stage, it is necessary to determine the molecular biological subtype (using genetic testing or by determining ER, PgR, and HER2 in combination with the determination of the proliferation marker Ki67).